Eli Lilly And Cao (NYSE:LLY) announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz).
A four year-long research study has found that particles secreted by an intestinal worm may assist in treating inflammatory ...
Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback